Abstract
This review highlights our studies of the nature of the true catalytic species in the Heck coupling of bromobenzene and styrene with conventionally prepared SiO2-supported Pd particles. Approaches including kinetic test, filtration test and catalyst poisoning were used to probe the behavior and nature of the possible active Pd species in combination with transmission electron microscopy and elemental analysis. We found that the catalytic activity of soluble Pd is suppressed in the presence of the supported Pd particles. Through a study of dependences of reaction rate on Pd loading and on leached Pd concentration, we demonstrated that the leached soluble Pd is responsible for the catalysis irrespectively of the supported Pd particles. With the aid of catalyst poisoning, we further illustrated that Pd clusters are inactive for the homogeneous Heck reaction, molecular Pd being solely active. We also discuss Pd scavenging from solution by solidbound thiols during the Heck reaction. In addition, we propose a ligand-free homogeneous Heck reaction mechanism with the generation of soluble molecular Pd0 by Pd leaching from conventionally prepared supported Pd particles.
Keywords: C-C coupling, Heck reaction, leaching, molecular Pd, Pd clusters, silica, supported Pd particles, true catalytic species
Current Organic Synthesis
Title: Recent Progress on the Studies of the True Catalyst in the Heck Reaction with Supported Pd Particles
Volume: 7 Issue: 6
Author(s): Lin Huang and Pui Kwan Wong
Affiliation:
Keywords: C-C coupling, Heck reaction, leaching, molecular Pd, Pd clusters, silica, supported Pd particles, true catalytic species
Abstract: This review highlights our studies of the nature of the true catalytic species in the Heck coupling of bromobenzene and styrene with conventionally prepared SiO2-supported Pd particles. Approaches including kinetic test, filtration test and catalyst poisoning were used to probe the behavior and nature of the possible active Pd species in combination with transmission electron microscopy and elemental analysis. We found that the catalytic activity of soluble Pd is suppressed in the presence of the supported Pd particles. Through a study of dependences of reaction rate on Pd loading and on leached Pd concentration, we demonstrated that the leached soluble Pd is responsible for the catalysis irrespectively of the supported Pd particles. With the aid of catalyst poisoning, we further illustrated that Pd clusters are inactive for the homogeneous Heck reaction, molecular Pd being solely active. We also discuss Pd scavenging from solution by solidbound thiols during the Heck reaction. In addition, we propose a ligand-free homogeneous Heck reaction mechanism with the generation of soluble molecular Pd0 by Pd leaching from conventionally prepared supported Pd particles.
Export Options
About this article
Cite this article as:
Huang Lin and Kwan Wong Pui, Recent Progress on the Studies of the True Catalyst in the Heck Reaction with Supported Pd Particles, Current Organic Synthesis 2010; 7(6) . https://dx.doi.org/10.2174/157017910794328565
DOI https://dx.doi.org/10.2174/157017910794328565 |
Print ISSN 1570-1794 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6271 |
Related Journals
Related Books

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Epigenetic Changes in the Methylation Patterns of KCNQ1 and WT1 after a Weight Loss Intervention Program in Obese Stroke Patients
Current Neurovascular Research Autophagy Modulators and Neuroinflammation
Current Medicinal Chemistry Soothing the Inflamed Brain: Effect of Non-Steroidal Anti-Inflammatory Drugs on Alzheimers Disease Pathology
CNS & Neurological Disorders - Drug Targets Lifestyle Changes among ACS Survivors in Arabian Gulf Countries (Gulf COAST Registry)
Current Vascular Pharmacology Lymphoid-Specific Tyrosine Phosphatase (Lyp): A Potential Drug Target For Treatment of Autoimmune Diseases
Current Drug Targets Relationships Between Alcohol Consumption, Smoking Status and Food Habits in Greek Adolescents. Vascular Implications for the Future
Current Vascular Pharmacology Targeting the Progression of Parkinsons Disease
Current Neuropharmacology Parkinson's Disease Management. Part II- Discovery of MAO-B Inhibitors Based on Nitrogen Heterocycles and Analogues
Current Topics in Medicinal Chemistry Development of HuperTacrines as Non-Toxic, Cholinesterase Inhibitors for the Potential Treatment of Alzheimer’s Disease
Mini-Reviews in Medicinal Chemistry A Review Focused on Molecular Mechanisms of Anxiolytic Effect of <i>Valerina officinalis</i> L. in Connection with Its Phytochemistry through <i>in vitro/in vivo</i> Studies
Current Pharmaceutical Design Selectivity Problems with Drugs Acting on Cardiac Na<sup>+</sup> and Ca<sup>2+</sup> Channels
Current Medicinal Chemistry Novel Targets for Apoptosis Modulation: BAG3 Protein and Other Co- Chaperones
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Ghrelin, A Novel Peptide Hormone in the Regulation of Energy Balance and Cardiovascular Function
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Immune and Metabolic Interactions of Human Erythrocytes: A Molecular Perspective
Endocrine, Metabolic & Immune Disorders - Drug Targets RNA Therapeutics Directed to the Non Coding Regions of APP mRNA, In Vivo Anti-Amyloid Efficacy of Paroxetine, Erythromycin, and N-acetyl cysteine
Current Alzheimer Research Radiopharmaceutical Chemistry with Iodine-124: A Non-Standard Radiohalogen for Positron Emission Tomography
Medicinal Chemistry Implications of Prion Protein Biology
Current Neurovascular Research Drugs of Abuse-Induced Hyperthermia, Blood-Brain Barrier Dysfunction and Neurotoxicity: Neuroprotective Effects of a New Antioxidant Compound H-290/51
Current Pharmaceutical Design Traumatic Brain Injury and Blood-Brain Barrier Cross-Talk
CNS & Neurological Disorders - Drug Targets The Radiosensitizing Effect of Olanzapine as an Antipsychotic Medication on Glioblastoma Cell
Current Radiopharmaceuticals